Skip to main content
logo
Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan flag Japan · Delayed Price · Currency is JPY
1,345.00
+50.00 (3.86%)
Aug 10, 2026, 3:30 PM JST

Sumitomo Pharma Balance Sheet

Millions JPY. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
76,64044,31036,28829,047143,478202,984
Cash & Short-Term Investments
76,64044,31036,28829,047143,478202,984
Cash Growth
274.71%22.11%24.93%-79.75%-29.32%4.79%
Accounts Receivable
139,508114,20271,51981,02395,908151,407
Other Receivables
3,27720,48512,76316,2162,72293
Receivables
142,785134,68784,28297,23998,630151,500
Inventory
79,67585,41496,917115,35094,40599,021
Other Current Assets
18,38214,84133,68227,93345,34746,016
Total Current Assets
317,482279,252253,168269,569381,860499,521
Property, Plant & Equipment
44,51144,23146,64857,89558,90964,091
Long-Term Investments
38,81836,4005,588182,368144,399127,909
Goodwill
214,385211,098197,406199,783209,415195,144
Other Intangible Assets
157,358160,474172,509195,652329,314398,692
Long-Term Deferred Tax Assets
6014215342,23910,84522,650
Other Long-Term Assets
71,72872,69566,751---
Total Assets
844,883804,571742,604907,5061,134,7421,308,007

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
48,86412,0839,22567,72052,14146,183
Short-Term Debt
-38,13042,440174,58890,5885,025
Current Portion of Long-Term Debt
41,000-4,000110,929-20,060
Current Portion of Leases
-1,9143,3543,7814,6605,463
Current Income Taxes Payable
1,8981,1201,5771,34824,0537,583
Other Current Liabilities
170,111218,253180,007157,108199,446194,059
Total Current Liabilities
261,873271,500240,603515,474370,888278,373
Long-Term Debt
119,658179,056258,982133,367244,128243,963
Long-Term Leases
-5,1165,4705,1996,99610,033
Pension & Post-Retirement Benefits
5,6595,6636,53411,1505,00811,461
Long-Term Deferred Tax Liabilities
15,68615,83626,55038,21136,50526,550
Other Long-Term Liabilities
33,45234,93334,98647,96964,43564,058
Total Liabilities
436,328512,104573,125751,370727,960634,438

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
71,32122,40022,40022,40022,40022,400
Additional Paid-In Capital
48,258----16,725
Retained Earnings
176,508158,98146,784-22,665280,999514,210
Treasury Stock
-685-684-682-682-682-681
Comprehensive Income & Other
113,153111,770100,977157,010104,03255,234
Total Common Equity
408,555292,467169,479156,063406,749607,888
Minority Interest
---733365,681
Shareholders' Equity
408,555292,467169,479156,136406,782673,569
Total Liabilities & Equity
844,883804,571742,604907,5061,134,7421,308,007

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
160,658224,216314,246427,864346,372284,544
Net Cash (Debt)
-84,018-179,906-277,958-398,817-202,894-81,560
Net Cash Growth
------
Net Cash Per Share
-206.50-452.83-699.64-1003.84-510.69-205.29
Filing Date Shares Outstanding
448.59397.29397.29397.29397.29397.29
Total Common Shares Outstanding
448.59397.29397.29397.29397.29397.29
Working Capital
55,6097,75212,565-245,90510,972221,148
Book Value Per Share
910.75736.16426.59392.821023.801530.08
Tangible Book Value
36,812-79,105-200,436-239,372-131,98014,052
Tangible Book Value Per Share
82.06-199.11-504.51-602.51-332.2035.37
Land
-1,5221,452---
Buildings
-69,97568,001---
Machinery
-72,65774,020---
Construction In Progress
-9,9229,468---